Takashi Kagari

1.4k citations
24 papers · 878 indexed · h-index 12
Topics
HER2/EGFR in Cancer Research (8 papers)Cell Adhesion Molecules Research (5 papers)Chemokine receptors and signaling (4 papers)

In The Last Decade

Takashi Kagari

24 papers receiving 864 citations

Peers

Takashi Kagari
Comparison fields: 5 of 77
  • Immunology 364
  • Oncology 302
  • Molecular Biology 276
  • Radiology, Nuclear Medicine and Imaging 217
  • Rheumatology 159
Replace Lihe Su with:
Lihe Su United States
Hyunbo Shim South Korea
Kunio Matsuta Japan
Jane Seagal United States
Taichi Sekine Japan
Rustom Falahati United States
Julia Jellusova Germany
Tammy P. Cheng United States
Elizabeth Pöhler United Kingdom
Paul M. Grandgenett United States
Takashi Kagari relative to Lihe Su United States Lihe Su's profile →
Citations per field
00.5×5.5×
Lihe Su · 1×
Citations per year

Countries citing papers authored by Takashi Kagari

Since Specialization
Citations

This map shows the geographic impact of Takashi Kagari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takashi Kagari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takashi Kagari more than expected).

Fields of papers citing papers by Takashi Kagari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takashi Kagari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takashi Kagari. The network helps show where Takashi Kagari may publish in the future.

Co-authorship network of co-authors of Takashi Kagari

This figure shows the co-authorship network connecting the top 25 collaborators of Takashi Kagari. A scholar is included among the top collaborators of Takashi Kagari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takashi Kagari. Takashi Kagari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 1
4 1
5 59
6 65
7 71
8 15
9 4
10 16
11 1
12 1
13 3
14 19
15 5
16 133
17 95
18 184
19 4
20 17

About Takashi Kagari

Takashi Kagari is a scholar working on Immunology and Allergy, Oncology and Immunology, having authored 24 papers that have together received 878 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (8 papers), Cell Adhesion Molecules Research (5 papers) and Chemokine receptors and signaling (4 papers). The work is most often cited by research in Immunology and Allergy (125 citations), Immunology (364 citations) and Oncology (302 citations). Takashi Kagari has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Hiromi Doi, Takaichi Shimozato, Daisuke Tanaka, Joyce Hu, Jonathan M. Clingan, Mehrdad Matloubian, Naoyuki Maeda, Kenji Hirotani, Kimio Yonesaka and Kazuto Nishio. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026